← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2003Last known activity
Jun 30, 2020
Timeline
2000s
- Jan 1, 2000
Galectin Therapeutics Inc.— Founded
Drugs by trial phase (7 distinct, 12 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Bile Duct Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Esophageal and Gastric Varices
- Fatty Liver
- Fibrosis
- Gallbladder Neoplasms
- Head and Neck Neoplasms
- Hypertension
- Hypertension, Portal
- Liver Cirrhosis
- Liver Diseases
- Lung Neoplasms
- Melanoma
- Non-alcoholic Fatty Liver Disease
- Psoriasis
- Squamous Cell Carcinoma of Head and Neck
- Varicose Veins
Recent trials (14)
- NCT04365868Lead sponsorPhase 2/Phase 3Jun 30, 2020
- NCT04365868Study directorPhase 2/Phase 3Jun 30, 2020
- NCT04332432Lead sponsorPhase 1Apr 30, 2020
- NCT02575404CollaboratorPhase 1Oct 1, 2015
- NCT02407041Lead sponsorPhase 2Sep 1, 2015
- NCT02421094Lead sponsorPhase 2Sep 1, 2015
- NCT02462967Lead sponsorPhase 2Jun 1, 2015
- NCT02117362CollaboratorPhase 1Mar 1, 2014
- NCT01899859Lead sponsorPhase 1Jul 1, 2013
- NCT00388700Lead sponsorPhase 2Oct 1, 2006
- NCT00386516Lead sponsorPhase 2Sep 1, 2006
- NCT00110721Lead sponsorPhase 2May 1, 2005
- NCT00054977Study directorPhase 1Feb 1, 2003
- NCT00054977Lead sponsorPhase 1Feb 1, 2003
Details
- Founded
- Norcross, GA, US Jan 1, 2000
- Last known activity
- Jun 30, 2020